RP Management, LLC
- SEC CIK
- 0001507673
- Latest filing
- Aug 6, 2025
Holdings in Q4 2021
Holdings as of Dec 31, 2021, filed Feb 14, 2022. Long positions only; changes compare share counts with Q3 2021.
- Positions
- 4
- +1 vs. Q3 2021
- Portfolio value
- $219.1M
- +$17.7M (+8.8%) vs. Q3 2021
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| BHVNBiohaven Ltd. | COM | 1,111,111 | $153.1M | 69.9% | 00.0% | Unchanged | History |
| BCRXBiocryst Pharmaceuticals Inc | COM | 3,846,154 | $43.0M | 19.6% | +3,846,154 | New | History |
| EPZMEpizyme, Inc. | COM | 9,166,667 | $22.9M | 10.5% | 00.0% | Unchanged | History |
| VIRXViracta Therapeutics, Inc. | COM | 3,700 | $13.5K | <0.1% | 00.0% | Unchanged | History |
Options (1)
Puts and calls in the same filing. Amounts are the market value of the underlying shares, which is what 13F reports.
| Security | Class | Puts | Calls |
|---|---|---|---|
| Epizyme Inc29428V904 | CALL | – | $6.37M |